We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 vaccine sales). While it historically sold many types of healthcare products and chemicals, now, prescription drugs and vaccines account for the majority of sales. Top sellers includ... Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 vaccine sales). While it historically sold many types of healthcare products and chemicals, now, prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, cardiovascular treatment Eliquis, and immunology drug Xeljanz. Pfizer sells these products globally, with international sales representing close to 50% of its total sales. Within international sales, emerging markets are a major contributor. Show more
Clinically meaningful and statistically significant results are the first pivotal Phase 3 data for sasanlimab, a subcutaneously administered PD-1 inhibitor If approved, sasanlimab would be the...
Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a discussion with Albert Bourla, Chairman and Chief Executive Officer, at the 43rd Annual J.P...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.1399 | -0.522014925373 | 26.8 | 26.87 | 25.96 | 32260082 | 26.34257864 | CS |
4 | 0.0201 | 0.0754504504504 | 26.64 | 27.57 | 25.96 | 32315835 | 26.6217737 | CS |
12 | -2.3499 | -8.10031023785 | 29.01 | 29.17 | 24.48 | 45141115 | 26.32093132 | CS |
26 | -3.4499 | -11.457655264 | 30.11 | 31.54 | 24.48 | 37146733 | 27.72825 | CS |
52 | -1.6599 | -5.86122881356 | 28.32 | 31.54 | 24.48 | 38501338 | 27.63837605 | CS |
156 | -27.8199 | -51.0644273128 | 54.48 | 56.32 | 24.48 | 30343459 | 35.6044119 | CS |
260 | -13.7499 | -34.0259836674 | 40.41 | 61.71 | 24.48 | 31433600 | 37.64671047 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions